CME - Hospital Cardiac Care: An Update for Inpatient Care

Venue: Hyatt Regency Sarasota

Location: Sarasota, Florida, United States

Event Date/Time: May 17, 2010 End Date/Time: May 21, 2010
Registration Date: May 17, 2010
Early Registration Date: Apr 17, 2010
Report as Spam


SPECIFIC OBJECTIVES FOR THIS COURSE: DAY 1 - ACUTE AORTIC SYNDROMES – Acute aortic syndromes and risk for this potentially lethal disease. The high lethality of acute aortic syndromes. Diagnostic imaging modalities and tests of choice for stable and unstable patients. Therapy and potential complications of acute aortic syndromes. Indications for emergency surgical intervention. SYNCOPE – Common underlying pathophysiology for virtually all causes. Benign and life-threatening causes. Diagnostic yield in the work-up. Clinical history to help focus the work-up. HYPOTENSION, CARDIAC SHOCK – The clinical presentation of hypotension to generate a differential diagnosis. Hemodynamic and clinical criteria used to define cardiogenic shock. Pathophysiology of cardiac shock. Treatment of cardiogenic shock and evidence behind the strategies. ADVANCED CARDIAC LIFE SUPPORT, POST-RESUSCITATION CARE – Changes in the most recent evidence-based American Heart Association guidelines for cardiopulmonary resuscitation. Phases and pathophysiology of cardiac arrest. Emerging concepts regarding cardiocerebral resuscitation. Strategies that may improve outcomes in post-resuscitation patients. DAY 2 - PERIOPERATIVE CARDIAC EVALUATION AND MANAGEMENT – What the surgical team wants to know. What the surgical team needs to know. Cardiovascular effects of anesthesia and surgery. Elements of preoperative evaluation, including the role of non-invasive testing for coronary artery disease. Perioperative measures which may reduce the risk of cardiac complications. CHEST PAIN, NON-INVASIVE TESTING FOR CORONARY ARTERY DISEASE – Differentiate life-threatening from more benign chest pain. Approach to chest pain, with the use of probability analysis. The relative merits of the various diagnostic tests for coronary artery disease. DYSPNEA – Pathophysiologic mechanisms. Differential diagnosis. Laboratory tests and diagnostic modalities used for evaluating dyspnea. Algorithms for the evaluation of patients with dyspnea. ABDOMINAL AORTIC ANEURYSM RUPTURE AND PERIPHERAL VASCULAR DISEASE – Evaluation of peripheral vascular disease. United States Preventative Services Task Force recommendations regarding screening for abdominal aortic aneurysm. Natural history of abdominal aortic aneurysm. ACC/AHA guidelines for the management of abdominal aortic aneurysm and peripheral vascular disease. DAY 3 - ACUTE ST- ELEVATION MYOCARDIAL INFARCTION – Relate the differences in plaque morphology to the differences between stable angina and acute coronary syndromes. Identify acute ST-elevation myocardial infarction, including the use of newer markers of cardiac injury. Treatment strategies that reduce mortality, and the importance of minimizing time delay. Complications of acute infarction. Post-infarction risk. ACUTE NON-STEMI/UNSTABLE ANGINA PECTORIS AND STABLE ANGINA – Unstable angina or non ST-elevation infarction, tailor therapy to the degree of risk. Which patient subgroups benefit from revascularization. Determinants of myocardial oxygen demand and supply, and the effects of medications on these determinants. Treatment of stable angina. INFECTIOUS ENDOCARDITIS – Clinical presentation and the echocardiographic assessment of infectious endocarditis. Current guidelines and evidence based recommendations of treatment of infectious endocarditis. Changes in AHA recommendations for infectious endocarditis prophylaxis. Management of complications of infectious endocarditis. INTERESTING CLINICAL CASES, PART I – Important clinical aspects in the diagnosis, evaluation and management of cardiac symptoms. Important clinical aspects in the diagnosis, evaluation and management of known cardiac diseases. When to refer complex patients for subspecialty care. DAY 4 - HYPERTENSIVE EMERGENCIES – Demographics and pathophysiology of hypertensive emergencies. Signs, symptoms and clinical characteristics of patients presenting with hypertensive emergencies. Differential diagnosis and appropriate work up of hypertensive emergencies. Treatment of hypertensive emergencies according to new JNC 7 Guidelines. PERICARDIAL DISEASES: PERICARDITIS AND TAMPONADE - Clinical presentation of acute and chronic pericarditis. Differential diagnosis and workup of acute and chronic pericarditis. Guideline and evidence-based driven treatment plan of pericarditis. Diagnosis and treatment plan of cardiac tamponade. ACUTE DECOMPENSATED HEART FAILURE – The evolving definitions of ADHF. Epidemiology and precipitating factors of ADHF. Differentiate ADHF from other etiologies of shortness of breath; treatment goals. Acute management involving the use of intravenous vasodilators and hemodynamic monitoring. Discharge criteria for ADHF. SUDDEN CARDIAC DEATH; AV BLOCK; BRADYARRHYTHMIAS – Types of slow cardiac rhythms. Electrocardiographic criteria for bradyarrhythmias. Indications for temporary pacemaker placement. Types of permanent pacemakers. Indications for permanent pacemaker placement. DAY 5 - ATRIAL FIBRILLATION AND FLUTTER – Etiology of the arrhythmias. Indications for anti-coagulation. Therapy for controlling ventricular response. Candidates for rate versus rhythm control. Candidates for radiofrequency ablation. SUPRAVENTRICULAR TACHYCARDIA – Mechanisms of supraventricular tachycardia. Specific types of supraventricular tachycardia. Differentiating ECG characteristics. Treatment options. INTERESTING CLINICAL CASES, PART II – Important clinical aspects in the diagnosis, evaluation and management of cardiac symptoms. Important clinical aspects in the diagnosis, evaluation and management of known cardiac diseases. When to refer complex patients for subspecialty care. ACUTE VALVE DISEASE (ACUTE AR AND MR) – Signs, symptoms, clinical presentation of acute AR and MR. Differential diagnosis and workup of acute AR and MR. Noninvasive imaging findings in acute AR and MR. ACC/AHA guidelines for treatment of acute AR and MR.


1000 Boulevard of the Arts
United States

Additional Information

Physician Fees $745.00 Regular Registration (30 days prior to seminar start date) $795.00 Late Registration Non Physician/Resident* Fees $645.00 Regular Registration (30 days prior to seminar start date) $695.00 Late Registration